✦ LIBER ✦

Antibody to Herpesvirus hominis types 1 and 2 in patients with hodgkin's disease and carcinoma of the nasopharynx

✍ Scribed by Louis W. Catalano Jr.; John M. Goldman

Publisher: John Wiley and Sons
Year: 1972
Tongue: English
Weight: 464 KB
Volume: 29
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197203)29:3<597::aid-cncr2820290311>3.0.co;2-h

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A high prevalence of antibody to the hep

A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan

✍ Kusuya Nishioka; Junnosuke Watanabe; Seiichi Furuta; Eiji Tanaka; Shiro Iino; Hi 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB 👁 2 views

In Japan, hepatocellular carcinoma (HCC) is one of the most prevalent cancers, with a reported fatality rate showing a consistent and significant increase in the last decade. At most, only 25% of HCC cases are positive for the hepatitis B surface antigen (HBsAg). To investigate a potential role for

Antibody against the Epstein-Barr virus

Antibody against the Epstein-Barr virus BHRF1 protein, a homologue of Bcl-2, in patients with nasopharyngeal carcinoma

✍ Liu, Mei-Ying; Shih, Ya-Yi; Chou, Sheng-Ping; Chen, Chien-Jen; Sheen, Tzung-Shia 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 2 views

The Epstein-Barr virus (EBV) open reading frame BHRF1, a homologue of the oncogene bcl-2, was cloned from a patient with nasopharyngeal carcinoma (NPC) and overexpressed in Escherichia coli. The resulting recombinant BHRF1 fusion protein, with an apparent molecular weight of 35 KD, was used as antig

Decreased lymphocytlc proliferation by m

Decreased lymphocytlc proliferation by mitogens in patients with transitional cell carcinoma of the renal pelvis subsequent to non-Hodgkin's lymphoma

✍ Sadaya Matano; Shinobu Nakamura; Kazumi Kobayashi; Toshimitu Misaki; Tamotsu Mat 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 397 KB 👁 2 views

Thyroglobulin may be undetectable in the

Thyroglobulin may be undetectable in the serum of patients with metastatic disease secondary to differentiated thyroid carcinoma. Follow-up of differentiated thyroid carcinoma

✍ Simon Grant; Brian Luttrell; Thomas Reeve; Josephine Wiseman; Errol Wilmshurst; 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 485 KB 👁 2 views

To assess the value of serum thyroglobulin (Tg) levels in the follow-up of differentiated thyroid carcinoma after ablative therapy simultaneous Tg estimations and radioiodine (I3'I) scans were performed on patients during an 18-month follow-up period. In this study, 287 scans were performed on 200 p

Phase I/II trial of 131I-MN-14 F(ab)2 an

Phase I/II trial of 131I-MN-14 F(ab)2 anti–carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma

✍ Malik E. Juweid; George Hajjar; Lawrence C. Swayne; Robert M. Sharkey; Samer Sul 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 1 views

## BACKGROUND. Monoclonal antibodies (MAbs) against carcinoembryonic antigen (CEA) have been recognized as targeting agents for medullary thyroid carcinoma (MTC). This Phase I/II study was initiated to determine the safety, maximum tolerated dose (MTD), and therapeutic potential of 131 I-MN-14 F(ab

Do the level of nodal disease according

Do the level of nodal disease according to the TNM classification and the number of involved cervical nodes reflect prognosis in patients with differentiated carcinoma of the thyroid gland?

✍ Sato, Nobuaki; Oyamatsu, Manabu; Koyama, Yu; Emura, Iwao; Tamiya, Yoichi; Hatake 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

Background and Objectives: The importance of nodal involvement as a prognostic factor in differentiated carcinoma of the thyroid gland remains controversial. We therefore attempted to confirm the prognostic factors in differentiated thyroid carcinoma, with special reference to nodal status. Patients